Over the course of his career, healthcare investor and entrepreneur Dr. Harry Stylli has provided executive leadership to numerous innovative companies. Dr. Harry Stylli currently serves as chairman of OncoCellMDx, a privately held diagnostic testing developer. Using technologies created internally and licensed through Harvard Medical School, the company has created non-invasive blood-based tests to evaluate a cancer’s grade and level of aggression.. Continue.
The field of cancer genomics continues to expand as scientists learn more and more about the intrinsic link between genetics and disease. In this article, we investigate DNA sequencing, from its beginnings to its potential in treating and preventing cancer. What is DNA sequencing? Our entire DNA is coded in an alphabet that consists… Continue Reading